ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 677696 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 677696; 2) Community: the network communities that were significantly associated with the response to NSC 677696; 3) Molecule: the relationships between components within communities and NSC 677696; 4) MDR: the compounds that were significantly associated with the NSC 677696.

NSC Compound Enrichment Correlation
NSC 700087 Bisoxireno[1,10a:3,4]phenanthro[3,2-b]furan-9(7aH)-one, 1,2, 3,4,4a,5,6,11a,11b,11c-decahydro-4,4,8,11c-tetramethyl-, [4aR-(4a.alpha.,6aS*,7a.beta.,10aR*,11a.beta.,11b.alpha.,11c.beta,)]- (9CI) 0.0385613993886 0.44088837
NSC 717189 Null 0.0385613993886 0.26584795
NSC 722392 Null 0.0385613993886 0.26397257
NSC 732832 1-{2-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrol ylamino)phenylcarboxamido]ethyl}-3,4-dimethoxybenzene 0.0385613993886 0.50178744
NSC 750104 5,10-dimethoxybenzo[g]quinolin-2(1H)-one 0.0385613993886 -0.37983338
NSC 762566 Null 0.0385613993886 -0.066539553
NSC 100880 Camptothecin 0.0385613993886001 -0.007307195
NSC 105014 Cladribine 0.0385613993886001 0.12352141
NSC 132313 Dianhydrogalactitol 0.0385613993886001 0.096716208
NSC 148790 Card-20(22)-enolide, 16-(acetyloxy)-3,14-dihydroxy-, (3.beta.,5.beta.,16.beta.)- (9CI) 0.0385613993886001 0.2326313
Total:96  Current:67    [First] [Prev] [Next] [Last]